Search

everythinglearnresearchcommunity

for

Search:↓

Androgens may block hair growth signals, targeting this could treat hair loss.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Meis1 is crucial for skin health and tumor development.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Researchers found new genes involved in hair growth, which could help develop new hair treatments.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Mutations in certain receptors can cause diseases and offer new treatment options.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

People undergoing chemotherapy need better support and information to cope with hair loss.